Ketoconazole as inhibitor of the enzyme CYP17 in locally advanced or disseminated granulosa cell tumors of the ovary (the GreKo I study) (gethi 11-03).

被引:1
|
作者
Garrigos, Laia
Hurtado, Alicia
Santaballa, Ana
Redondo, Andres
Lainez, Nuria
Vidal Boixader, Laura
Guerra Alia, Eva
Rodriguez, Victor
Fernando Cueva, Juan
Bover, Isabel
Palacio, Isabel
Jesus Rubio, M.
Prieto, Mario
Antonio Lopez-Guerrero, Jose
Romero, Nuria
Garcia-Casado, Zaida
Garcia-Martinez, Elena
Grande, Enrique
Garcia-Donas, Jesus
机构
[1] Hosp del Mar, Med Oncol, Barcelona, Spain
[2] Hosp Univ Fdn Alcorcon, Alcorcon, Spain
[3] Hosp Univ & Politccn La Fe, Valencia, Spain
[4] Hosp Univ La Paz, Madrid, Spain
[5] Complejo Hosp Navarra, Pamplona, Spain
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Hosp Univ Ramon y Cajal, Madrid, Spain
[8] Hosp Valle Ebron, Barcelona, Spain
[9] Complexo Hosp Univ Santiago de Compostela, Santiago De Compostela, Spain
[10] GEICO, Mallorca, Spain
[11] Son Llatzer Univ Hosp, Mallorca, Spain
[12] Univ Oviedo, Hosp Cent Asturias, E-33080 Oviedo, Spain
[13] Hosp Reina Sofia, Cordoba, Spain
[14] Ctr Integral Oncol Clara Campal, Madrid, Spain
[15] Inst Valenciano Oncol, Mol Biol Lab, Valencia, Spain
[16] Ctr Integral Oncol CLara Campal, Madrid, Spain
[17] Hosp Gen Univ Morales Meseguer, Med Oncol, Murcia, Spain
[18] Hosp Univ Ramon y Cajal, Dept Med Oncol, Madrid, Spain
关键词
D O I
10.1200/jco.2014.32.15_suppl.5558
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5558
引用
收藏
页数:1
相关论文
共 2 条
  • [1] Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03
    Jesus Garcia-Donas
    Alicia Hurtado
    Laia Garrigos
    Ana Santaballa
    Andres Redondo
    Laura Vidal
    Nuria Lainez
    Eva Guerra
    Victor Rodriguez
    Juan Cueva
    Isabel Bover
    Isabel Palacio
    Maria Jesus Rubio
    Mario Prieto
    Jose Antonio Lopez-Guerrero
    Juan Francisco Rodriguez-Moreno
    Zaida Garcia-Casado
    Elena Garcia-Martinez
    Alvaro Taus
    Ignacio Pérez de Castro
    Paloma Navarro
    Enrique Grande
    Clinical and Translational Oncology, 2023, 25 : 2090 - 2098
  • [2] Open-label phase II clinical trial of ketoconazole as CYP17 inhibitor in metastatic or advanced non-resectable granulosa cell ovarian tumors: the GREKO (GRanulosa Et KetOconazole) trial, GETHI 2011-03
    Garcia-Donas, Jesus
    Hurtado, Alicia
    Garrigos, Laia
    Santaballa, Ana
    Redondo, Andres
    Vidal, Laura
    Lainez, Nuria
    Guerra, Eva
    Rodriguez, Victor
    Cueva, Juan
    Bover, Isabel
    Palacio, Isabel
    Rubio, Maria Jesus
    Prieto, Mario
    Lopez-Guerrero, Jose Antonio
    Rodriguez-Moreno, Juan Francisco
    Garcia-Casado, Zaida
    Garcia-Martinez, Elena
    Taus, Alvaro
    de Castro, Ignacio Perez
    Navarro, Paloma
    Grande, Enrique
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (07): : 2090 - 2098